购物车
0
有库存
HIT212713952
 sdf 文件
结构编辑
类似物检索
HIT212713952
  • HIT ID:HIT212713952
  • Cas No:180422-22-4;762219-35-2
  • 常用名:XR9051
  • IUPAC:N-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]phenyl}-3-{[(2Z,5Z)-4-methyl-3,6-dioxo-5-(phenylmethylidene)piperazin-2-ylidene]methyl}benzamide
    IUPAC:N-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]phenyl}-3-{[(2Z,5Z)-4-methyl-3,6-dioxo-5-(phenylmethylidene)piperazin-2-ylidene]methyl}benzamide
  • InChI key:RTIZZWMBGKGLFO-YWQXDYITSA-N
  • 分子式:C39H38N4O5
  • 分子量:642.756
  • 氢键供体数 (HBD):2
  • 氢键受体数 (HBA):6
  • LogP:4.699954
  • SMILES:COc1cc2CCN(CCc3ccc(NC(=O)c4cccc(\C=c5/[nH]c(=O)\c(=C\c6ccccc6)n(C)c5=O)c4)cc3)Cc2cc1OC
    SMILES:COc1cc2CCN(CCc3ccc(NC(=O)c4cccc(\C=c5/[nH]c(=O)\c(=C\c6ccccc6)n(C)c5=O)c4)cc3)Cc2cc1OC
  • XR9051 is as a potent modulator of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) following a synthetic chemistry programme based on a natural product lead compound. XR9051 was shown to be a potent inhibitor of the binding of the cytotoxic to P-glycoprotein (EC50 = 1.4 +/- 0.5 nM). XR9051 reverses the MDR phenotype through direct interaction with P-glycoprotein.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    8-10周
    纯度
    -
    ¥ 12,800.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~